Hikal Ltd
HIKALHikal Ltd
HIKAL
Price Chart
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 38.68 | 3.21 | 0.41% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 40.65 | 4.77 | 0.76% |
Forecast & Ratings
Detailed Forecastfrom 1 analyst
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Hikal Limited is engaged in the manufacturing of various chemical intermediates, specialty chemicals, active pharmaceutical ingredients and contract research activities. The Company offers pharmaceuticals and agrochemicals.
Investor Presentation
View olderPeers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Mankind Pharma Ltd
Torrent Pharmaceuticals Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 873.43 | 927.49 | 1,017.38 | 1,300.55 | 1,591.87 | 1,510.96 | 1,725.42 | 1,947.61 | 2,028.44 | 2,037.37 | ||||||||||
Raw Materials | 431.89 | 447.77 | 494.83 | 715.32 | 868.80 | 781.90 | 906.71 | 1,032.21 | 1,121.59 | 1,749.68 | ||||||||||
| Power & Fuel Cost | 93.85 | 83.70 | 85.63 | 108.41 | 132.04 | 129.99 | 147.83 | 175.46 | 186.91 | |||||||||||
| Employee Cost | 90.84 | 109.65 | 116.69 | 128.06 | 135.69 | 156.57 | 164.32 | 203.38 | 222.44 | |||||||||||
| Selling & Administrative Expenses | 41.58 | 41.63 | 43.74 | 45.90 | 52.50 | 55.57 | 64.05 | 95.21 | 105.43 | |||||||||||
| Operating & Other expenses | 31.29 | 62.06 | 78.80 | 56.67 | 102.46 | 125.48 | 114.64 | 95.91 | 129.59 | |||||||||||
EBITDA | 183.98 | 182.68 | 197.69 | 246.19 | 300.38 | 261.45 | 327.87 | 345.44 | 262.48 | 287.69 | ||||||||||
| Depreciation/Amortization | 64.19 | 67.28 | 69.14 | 85.59 | 92.88 | 82.46 | 85.25 | 95.67 | 109.01 | 110.24 | ||||||||||
| PBIT | 119.79 | 115.40 | 128.55 | 160.60 | 207.50 | 178.99 | 242.62 | 249.77 | 153.47 | 177.45 | ||||||||||
| Interest & Other Items | 60.05 | 62.21 | 48.27 | 49.12 | 58.43 | 52.42 | 36.20 | 31.22 | 48.10 | 50.60 | ||||||||||
| PBT | 59.74 | 53.19 | 80.28 | 111.48 | 149.07 | 126.57 | 206.42 | 218.55 | 105.37 | 126.85 | ||||||||||
| Taxes & Other Items | 19.35 | 11.99 | 12.54 | 34.27 | 46.01 | 42.14 | 73.28 | 58.06 | 26.99 | 32.68 | ||||||||||
| Net Income | 40.39 | 41.20 | 67.74 | 77.21 | 103.06 | 84.43 | 133.14 | 160.49 | 78.38 | 94.17 | ||||||||||
| EPS | 3.28 | 3.34 | 5.49 | 6.26 | 8.36 | 6.85 | 10.80 | 13.02 | 6.36 | 7.64 | ||||||||||
| DPS | 0.67 | 0.67 | 0.80 | 0.80 | 1.20 | 1.20 | 2.00 | 1.60 | 1.20 | 1.00 | ||||||||||
| Payout ratio | 0.20 | 0.20 | 0.15 | 0.13 | 0.14 | 0.18 | 0.19 | 0.12 | 0.19 | 0.13 |
Company Updates
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Hikal Ltd | 46.47 | 3.21 | 0.41% |
| Sun Pharmaceutical Industries Ltd | 32.81 | 4.69 | 0.99% |
| Cipla Ltd | 34.18 | 4.04 | 0.72% |
| Dr Reddy's Laboratories Ltd | 20.63 | 3.99 | 0.72% |
Price Comparison
Compare HIKAL with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Sep 2022
Dec 2022
Mar 2023
Jun 2023
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Hikal Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
Tata Small Cap Fund-Direct Plan-Growth Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 2.6946% | Percentage of the fund’s portfolio invested in the stock 1.62% | Change in the portfolio weight of the stock over the last 3 months -0.13% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 46/66 (-4) |
NIPPON INDIA NIFTY SMALLCAP 250 INDEX FUND-DIRECT PLAN-GROWTH Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.0152% | Percentage of the fund’s portfolio invested in the stock 0.09% | Change in the portfolio weight of the stock over the last 3 months -0.02% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 244/253 (-2) |
Motilal Oswal Nifty Smallcap 250 Index Fund Direct Growth Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.0098% | Percentage of the fund’s portfolio invested in the stock 0.09% | Change in the portfolio weight of the stock over the last 3 months -0.02% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 244/251 (-2) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividend Cuts
HIKAL has increased or maintained dividend levels over the last 5 years
Dividend Yield
Current dividend yield is 0.41%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹4.08 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateSep 18, 2023
Dividend/Share
₹0.60
Ex DateEx Date
Sep 18, 2023
Cash Dividend
Ex DateEx DateFeb 14, 2023
Dividend/Share
₹0.60
Ex DateEx Date
Feb 14, 2023
Cash Dividend
Ex DateEx DateSep 14, 2022
Dividend/Share
₹0.40
Ex DateEx Date
Sep 14, 2022
Cash Dividend
Ex DateEx DateFeb 23, 2022
Dividend/Share
₹1.20
Ex DateEx Date
Feb 23, 2022
Cash Dividend
Ex DateEx DateAug 25, 2021
Dividend/Share
₹1.00
Ex DateEx Date
Aug 25, 2021
News & Opinions
Kalyani Group firms deny being party to any family pact
1 month ago•The Hindu Businessline
Hikal discloses family pact of promoters to meet Sebi norms
1 month ago•Economic Times
Hikal Consolidated June 2023 Net Sales at Rs 388.05 crore, up 2.44% Y-o-Y
1 month ago•Moneycontrol
Hikal Q1 results: Pharma firm swings to Rs 6.92 crore profit
1 month ago•Moneycontrol
Hikal share price rises nearly 2% after GPCB withdrawn closure order
1 month ago•Moneycontrol
Exit Hikal, rather go for UPL as a long-term buy: Sudip Bandyopadhyay
2 months ago•Economic Times
Stocks that will see action: July 24, 2024
2 months ago•The Hindu Businessline
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 9.3%, vs industry avg of 8.45%
Constant Market Share
Over the last 5 years, market share stayed at 0.64%
Lower than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 0.3%, vs industry avg of 9.81%